New drug targeting DNA repair shows promise in range of advanced cancers
New drug targeting DNA repair shows promise in range of advanced cancers A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors. The drug candidate, tested in humans for the first time, […]
Read More